Engel B, Karl I, Napierala H, Truthmann J (2025)
Publication Type: Journal article
Publication year: 2025
DOI: 10.1007/s44266-025-00385-y
Gout is one of the most widespread forms of arthritis worldwide. In Germany, it is usually treated by general practitioners. An acute gout attack is usually diagnosed on a clinical basis. Treatment options for acute gout include nonsteroidal anti-inflammatory drugs (NSAIDs), colchicine or glucocorticoids. Gout is often associated with various comorbidities such as hypertension or renal insufficiency. However, the association is complex and multifactorial, whereby a causal effect of hyperuricemia on chronic kidney disease has not yet been clearly proven. Uric acid-lowering therapy should be initiated in the case of severely impairing attacks, more than one gout attack per year, and tophaceous gout. First choice medication is allopurinol. Asymptomatic hyperuricemia without gout is not an indication for uric acid-lowering therapy.
APA:
Engel, B., Karl, I., Napierala, H., & Truthmann, J. (2025). Update: gout in the primary care setting based on the interdisciplinary S3 guideline on diagnosis and treatment of gout Update: Gicht in der Hausarztpraxis auf Grundlage der interdisziplinären S3-Leitlinie Diagnostik und Therapie der Gicht. Zeitschrift für Allgemeinmedizin. https://doi.org/10.1007/s44266-025-00385-y
MLA:
Engel, Bettina, et al. "Update: gout in the primary care setting based on the interdisciplinary S3 guideline on diagnosis and treatment of gout Update: Gicht in der Hausarztpraxis auf Grundlage der interdisziplinären S3-Leitlinie Diagnostik und Therapie der Gicht." Zeitschrift für Allgemeinmedizin (2025).
BibTeX: Download